ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Neuphoria Therapeutics Inc
6.24
+2.19
54.07%
盤後:
5.91
-0.3296
-5.28%
19:59 EDT
成交量:
8,366.96萬
成交額:
5.44億
市值:
1,471.15萬
市盈率:
-27.40
高:
8.44
開:
6.30
低:
5.66
收:
4.05
52周最高:
21.40
52周最低:
2.90
股本:
235.76萬
流通股本:
122.78萬
量比:
92.40
換手率:
6814.60%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.2278
每股收益(LYR):
-0.2278
淨資產收益率:
-2.03%
總資產收益率:
-1.84%
市淨率:
0.77
市盈率(LYR):
-27.40
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Neuphoria Therapeutics Inc
交易所:
NASDAQ
成立時間:
1996
員工人數:
8
公司地址:
100 Summit Drive,Burlington,Massachusetts,United States
官網:
http://www.neuphoriatx.com
郵編:
01803
電話:
781 439 5551
傳真:
- -
簡介:
Neuphoria Therapeutics Inc.(原名Bionomics Limited)於1996年根據澳大利亞法律註冊成立,並於2024年12月24日遷移至特拉華州並成為國內公司。作為一家臨床階段的生物技術公司,它開發神經精神障礙療法。其主要候選藥物BNC210(口服選擇性α 7煙鹼性ACH受體調節劑)針對急性SAD和慢性PTSD,超過2700萬美國患者的需求未得到滿足。BNC210是一種首創的抗焦慮療法,可在沒有鎮靜、認知問題或成癮的情況下快速恢復神經遞質平衡。它與默沙東(美國/加拿大以外)就兩種早期臨床CNS藥物建立了合作夥伴關係。其管線包括下一代α 7受體和KV3.1/3.2臨床前項目(先導優化)。目前的治療方法(抗抑鬱藥、苯二氮卓類藥物)幾十年來缺乏FDA的新批准,存在缺陷;BNC210在試驗中显示出快速的作用和沒有限制性副作用。
董事
名稱
職位
Spyros Papapetropoulos
Chief Executive Officer and Director and President
Alan Fisher
Director
David Wilson
Director
Jane Ryan
Director
Miles Davies
Director
股東
名稱
職位
Spyros Papapetropoulos
Chief Executive Officer and Director and President
Tim Cunningham
Chief Financial Officer and Principal Financial Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/NEUP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NEUP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","market":"US","secType":"STK","nameCN":"Neuphoria Therapeutics Inc","latestPrice":6.24,"timestamp":1761336000000,"preClose":4.05,"halted":0,"volume":83669632,"hourTrading":{"tag":"盘后","latestPrice":5.9104,"preClose":6.24,"latestTime":"19:59 EDT","volume":483735,"amount":2909456.9434,"timestamp":1761350389729},"delay":0,"floatShares":1227800,"shares":2357613,"eps":-0.227756,"marketStatus":"休市中","change":2.19,"latestTime":"10-24 16:00:00 EDT","open":6.3,"high":8.44,"low":5.66,"amount":543784082.571392,"amplitude":0.68642,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.227756,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1761552000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.05,"preHourTrading":{"tag":"盘前","latestPrice":6.2902,"preClose":4.05,"latestTime":"09:29 EDT","volume":13047679,"amount":75692404.177664,"timestamp":1761312599803},"postHourTrading":{"tag":"盘后","latestPrice":5.9104,"preClose":6.24,"latestTime":"19:59 EDT","volume":483735,"amount":2909456.9434,"timestamp":1761350389729},"volumeRatio":92.39660915373345},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEUP\",,,,,undefined,":{"symbol":"NEUP","floatShares":1227800,"roa":"-1.84%","roe":"-2.03%","lyrEps":-0.227756,"volumeRatio":92.39660915373345,"shares":2357613,"dividePrice":0,"high":8.44,"amplitude":0.68642,"preClose":4.05,"low":5.66,"week52Low":2.9,"pbRate":"0.77","psRate":"0.94","week52High":21.4004,"institutionHeld":0.1011,"latestPrice":6.24,"eps":-0.227756,"divideRate":0,"volume":83669632,"delay":0,"ttmEps":-0.227756,"open":6.3,"prevYearClose":3.43,"prevWeekClose":15.52,"prevMonthClose":11.79,"prevQuarterClose":11.79,"fiveDayClose":15.52,"twentyDayClose":12.31,"sixtyDayClose":8.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEUP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-09-29","symbol":"NEUP","fiscalQuarterEnding":"2025/06","expectedEps":-0.56,"name":null,"time":"盤後","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"post","actualEps":-5.79},{"market":"US","date":"2024-12-24","symbol":"NEUP","defaultRemindTime":1735050600000,"type":"split","dateTimestamp":1735016400000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEUP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEUP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1757563200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NEUP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NEUP","date":"2025-10-24","current":-27.397741,"percent":0.115942,"low":-2152.911097,"twenty":-1.112407,"median":-0.681767,"eighty":2.474697,"high":4.870093,"avg":-46.653153,"sd":237.165869,"marketCap":9548332},"quantilePoints":[{"date":"2024-12-27","current":-1445.015744,"twenty":-2011.332026,"median":-1798.963421,"eighty":-1586.594815,"marketCap":15641406744},{"date":"2025-01-03","current":-951.437333,"twenty":-1445.015744,"median":-1245.311321,"eighty":-1113.798652,"marketCap":10298723991},{"date":"2025-01-10","current":-0.484092,"twenty":-1335.908938,"median":-1032.617992,"eighty":-0.531583,"marketCap":5240001},{"date":"2025-01-17","current":-0.452507,"twenty":-1207.318772,"median":-0.536694,"eighty":-0.48107,"marketCap":4898109},{"date":"2025-01-24","current":-0.524667,"twenty":-1141.075354,"median":-0.511137,"eighty":-0.48107,"marketCap":5679203},{"date":"2025-01-31","current":-0.81331,"twenty":-1016.381861,"median":-0.554735,"eighty":-0.482883,"marketCap":8803579},{"date":"2025-02-07","current":-0.757686,"twenty":-381.062919,"median":-0.702062,"eighty":-0.484985,"marketCap":8201486},{"date":"2025-02-14","current":-0.691539,"twenty":-0.803388,"median":-0.699056,"eighty":-0.486483,"marketCap":7485483},{"date":"2025-02-21","current":-1.080318,"twenty":-1.103422,"median":-0.706573,"eighty":-0.495533,"marketCap":8872986},{"date":"2025-02-28","current":-1.110267,"twenty":-1.105989,"median":-0.757686,"eighty":-0.509378,"marketCap":9118970},{"date":"2025-03-07","current":-1.180862,"twenty":-1.111551,"median":-0.770464,"eighty":-0.516549,"marketCap":9698789},{"date":"2025-03-14","current":-1.035394,"twenty":-1.111551,"median":-0.796773,"eighty":-0.529478,"marketCap":8504010},{"date":"2025-03-21","current":-1.108128,"twenty":-1.110267,"median":-1.022558,"eighty":-0.551126,"marketCap":9101399},{"date":"2025-03-28","current":-1.240761,"twenty":-1.1415,"median":-1.048229,"eighty":-0.607653,"marketCap":10190756},{"date":"2025-04-04","current":-1.210812,"twenty":-1.180862,"median":-1.055716,"eighty":-0.664779,"marketCap":9944772},{"date":"2025-04-11","current":-1.048229,"twenty":-1.179151,"median":-1.052508,"eighty":-0.679813,"marketCap":8609432},{"date":"2025-04-17","current":-1.093153,"twenty":-1.172305,"median":-1.056786,"eighty":-0.692441,"marketCap":8978407},{"date":"2025-04-25","current":-1.110267,"twenty":-1.154335,"median":-1.064274,"eighty":-0.697252,"marketCap":9118970},{"date":"2025-05-02","current":-1.069622,"twenty":-1.152624,"median":-1.071761,"eighty":-0.702663,"marketCap":8785135},{"date":"2025-05-09","current":-1.056786,"twenty":-1.146207,"median":-1.070692,"eighty":-0.70567,"marketCap":8679713},{"date":"2025-05-16","current":-1.014001,"twenty":-1.12567,"median":-1.069622,"eighty":-0.714089,"marketCap":8328307},{"date":"2025-05-23","current":1.878545,"twenty":-1.12567,"median":-1.066199,"eighty":-0.70567,"marketCap":10946278},{"date":"2025-05-30","current":2.090639,"twenty":-1.118824,"median":-1.058925,"eighty":-0.691539,"marketCap":12182153},{"date":"2025-06-06","current":2.306801,"twenty":-1.112407,"median":-1.056786,"eighty":-0.536694,"marketCap":13441728},{"date":"2025-06-13","current":2.303575,"twenty":-1.112407,"median":-1.053577,"eighty":-0.487084,"marketCap":13422928},{"date":"2025-06-20","current":2.135807,"twenty":-1.112407,"median":-1.052016,"eighty":-0.48107,"marketCap":12445348},{"date":"2025-06-27","current":2.193881,"twenty":-1.110695,"median":-1.048229,"eighty":-0.028511,"marketCap":12783741},{"date":"2025-07-03","current":2.300349,"twenty":-1.110267,"median":-1.04609,"eighty":1.971267,"marketCap":13404129},{"date":"2025-07-11","current":2.451984,"twenty":-1.110267,"median":-1.029511,"eighty":2.139033,"marketCap":14287711},{"date":"2025-07-18","current":2.416495,"twenty":-1.110267,"median":-1.009723,"eighty":2.183557,"marketCap":14080915},{"date":"2025-07-25","current":2.710088,"twenty":-1.108984,"median":-0.902959,"eighty":2.199559,"marketCap":15791680},{"date":"2025-08-01","current":2.616525,"twenty":-1.108128,"median":-0.783243,"eighty":2.258407,"marketCap":15246491},{"date":"2025-08-08","current":2.500379,"twenty":-1.107461,"median":-0.765954,"eighty":2.294542,"marketCap":14569705},{"date":"2025-08-15","current":2.613299,"twenty":-1.106066,"median":-0.738143,"eighty":2.306801,"marketCap":15227692},{"date":"2025-08-22","current":2.232596,"twenty":-1.104483,"median":-0.703565,"eighty":2.308091,"marketCap":13009337},{"date":"2025-08-29","current":3.939307,"twenty":-1.101283,"median":-0.691539,"eighty":2.322933,"marketCap":22954336},{"date":"2025-09-05","current":3.845744,"twenty":-1.099571,"median":-0.659969,"eighty":2.388052,"marketCap":22409147},{"date":"2025-09-12","current":4.513587,"twenty":-1.099503,"median":-0.53068,"eighty":2.412623,"marketCap":26300668},{"date":"2025-09-19","current":3.032718,"twenty":-1.096901,"median":-0.508206,"eighty":2.459921,"marketCap":17671642},{"date":"2025-09-26","current":4.016738,"twenty":-1.093153,"median":-0.484837,"eighty":2.484247,"marketCap":23405526},{"date":"2025-10-03","current":-93.377884,"twenty":-1.099571,"median":-0.487084,"eighty":2.484247,"marketCap":34515454},{"date":"2025-10-10","current":-121.187146,"twenty":-1.107683,"median":-0.517902,"eighty":2.484247,"marketCap":44794647},{"date":"2025-10-17","current":-96.758368,"twenty":-1.110267,"median":-0.572775,"eighty":2.482957,"marketCap":35764989},{"date":"2025-10-24","current":-25.831995,"twenty":-1.112407,"median":-0.681767,"eighty":2.474697,"marketCap":9548332}],"updateTime":1761480884094},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":3331473,"yearFounded":1996,"employeeNum":8,"address":"100 Summit Drive,Burlington,Massachusetts,United States","zipCode":"01803","officePhone":"781 439 5551"},"stockCompanyDetail":{"websiteUrl":"http://www.neuphoriatx.com","stockEarnings":[{"period":"1week","weight":-0.5979},{"period":"1month","weight":-0.455},{"period":"3month","weight":-0.2659},{"period":"6month","weight":0.2381},{"period":"1year","weight":1.0545},{"period":"ytd","weight":0.8192}],"compareEarnings":[{"period":"1week","weight":0.0194},{"period":"1month","weight":0.0244},{"period":"3month","weight":0.063},{"period":"6month","weight":0.2299},{"period":"1year","weight":0.1692},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Neuphoria Therapeutics Inc.(原名Bionomics Limited)於1996年根據澳大利亞法律註冊成立,並於2024年12月24日遷移至特拉華州並成為國內公司。作為一家臨床階段的生物技術公司,它開發神經精神障礙療法。其主要候選藥物BNC210(口服選擇性α 7煙鹼性ACH受體調節劑)針對急性SAD和慢性PTSD,超過2700萬美國患者的需求未得到滿足。BNC210是一種首創的抗焦慮療法,可在沒有鎮靜、認知問題或成癮的情況下快速恢復神經遞質平衡。它與默沙東(美國/加拿大以外)就兩種早期臨床CNS藥物建立了合作夥伴關係。其管線包括下一代α 7受體和KV3.1/3.2臨床前項目(先導優化)。目前的治療方法(抗抑鬱藥、苯二氮卓類藥物)幾十年來缺乏FDA的新批准,存在缺陷;BNC210在試驗中显示出快速的作用和沒有限制性副作用。","exchange":"NASDAQ","name":"Neuphoria Therapeutics Inc","nameEN":"Neuphoria Therapeutics Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NEUP\",market:\"US\",,,undefined,":{"directors":[{"name":"Spyros Papapetropoulos","position":"Chief Executive Officer and Director and President"},{"name":"Alan Fisher","position":"Director"},{"name":"David Wilson","position":"Director"},{"name":"Jane Ryan","position":"Director"},{"name":"Miles Davies","position":"Director"}],"executives":[{"name":"Spyros Papapetropoulos","position":"Chief Executive Officer and Director and President"},{"name":"Tim Cunningham","position":"Chief Financial Officer and Principal Financial Officer"}]}}}